(Q54564134)

1 June 2018

title

Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases. (English)

1 reference

1 June 2018

main subject

neoplastic stem cells

1 reference

1 reference

5

1 reference

1 June 2018

Marc Colombel

object named as

Marc Colombel

1

0 references

author name string

Colby L Eaton

2

1 reference

1 June 2018

Freddy Hamdy

3

1 reference

1 June 2018

Estelle Ricci

4

1 reference

1 June 2018

Marco Cecchini

6

1 reference

1 June 2018

Florence Mege-Lechevallier

7

1 reference

1 June 2018

Philippe Clezardin

8

1 reference

1 June 2018

George Thalmann

9

1 reference

1 June 2018

publication date

31 August 2011

1 reference

1 June 2018

published in

The Prostate

1 reference

1 June 2018

volume

72

1 reference

1 June 2018

issue

7

1 reference

1 June 2018

page(s)

713-720

1 reference

1 June 2018

Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Pathologic fracture and metastatic spinal cord compression in patients with prostate cancer and bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Examining the metastatic niche: targeting the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Implications of bone metastases and the benefits of bone-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

CD133, a novel marker for human prostatic epithelial stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Apoptosis in prostate cancer. Molecular basis to study hormone refractory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Stem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Expression analysis of putative stem cell markers in human benign and malignant prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Integrins in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

Expression of CD44s in incidental prostate cancer is more strongly associated with Gleason scores on subsequent radical prostatectomies than conventional prognostic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21473

21 January 2018

Identifiers

DOI

10.1002/PROS.21473

1 reference

1 June 2018

1 reference

1 June 2018